Trial Information

Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting

Objective 1: All new cancer patients seen for a four month period at the University of New
Mexico Cancer Research and Treatment Center (UNM CRTC) (academic population) and for a six
month-period at the New Mexico Cancer Care Alliance (NMCCA) (community setting). A careful
screening log will be kept during this period with the research nurses cooperation in
documenting 1) whether patients seen were accrued to a clinical trial, 2) what available
trials the patient might possibly be eligible for, and 3) the reason for not registering on
to a clinical trial.

Objective 2: To compare the responses to questions on the entry forms of those women who
were eligible and declined participation to those who participated by Hispanic versus
non-Hispanic ethnicity, we will access, copy, and analyze all the risk assessment profiles
otherwise known as entry or eligibility forms completed by women who considered
participating in the study of Tamoxifen and Raloxifene (STAR). Patterns of eligibility
criteria and risk assessment will be described by ethnicity of women considered for entry
into this chemopreventive randomized trial without the use of personal identifying data in
accordance with the Health Insurance Portability Accountability Act of 1996 to maintain
patient confidentiality